Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma

NCT00575406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: liposomal Doxorubicin
DRUG: Vincristin
DRUG: Prednisolone

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie